Interplay of troponin- and Myosin-based pathways of calcium activation in skeletal and cardiac muscle: the use of W7 as an inhibitor of thin filament activation.
about
Targets for therapy in sarcomeric cardiomyopathiesStructure of the Inhibitor W7 Bound to the Regulatory Domain of Cardiac Troponin CSolution Structure of Human Cardiac Troponin C in Complex with the Green Tea Polyphenol, (-)-Epigallocatechin 3-GallateSolution structure of the regulatory domain of human cardiac troponin C in complex with the switch region of cardiac troponin I and W7: The basis of W7 as an inhibitor of cardiac muscle contractionTargeting the sarcomere to correct muscle functionStructure and function of cardiac troponin C (TNNC1): Implications for heart failure, cardiomyopathies, and troponin modulating drugsSarcomere lattice geometry influences cooperative myosin binding in muscle.Interaction of cardiac troponin with cardiotonic drugs: a structural perspective.Increased Titin Compliance Reduced Length-Dependent Contraction and Slowed Cross-Bridge Kinetics in Skinned Myocardial Strips from Rbm (20ΔRRM) Mice.Sarcomere neutralization in inherited cardiomyopathy: small-molecule proof-of-concept to correct hyper-Ca2+-sensitive myofilamentsProbing the mechanism of cardiovascular drugs using a covalent levosimendan analog.Cardiac length dependence of force and force redevelopment kinetics with altered cross-bridge cycling.Effects of cross-bridge compliance on the force-velocity relationship and muscle power output.Myosin MgADP release rate decreases at longer sarcomere length to prolong myosin attachment time in skinned rat myocardium.
P2860
Q27027023-28512EF1-8F58-4C54-BEEF-CAA36A9EF764Q27655388-20C4FC24-D3B1-4620-8255-7B373EE45174Q27656100-A87FD7D7-453B-4768-BB27-5BA6A7205159Q27659302-3EA34F99-E7E1-4216-8CF8-B1E1B7DFFE03Q28260629-EF0910BC-3B88-4FDE-A97B-D89CB3A5FA32Q28607749-2D7C54EB-8799-4B88-8780-E834619813F0Q33290825-9E7B4C42-1B21-4CE3-AC49-DAD0DDE15159Q36595569-5F202418-FE7B-4CBD-BEAB-666C2E8A7E32Q37137855-AEA853CC-4E95-482C-A05C-D6A361C22B27Q37139625-B8F5DC1A-E25F-4A6E-A902-253C1CAFDDF4Q40151421-AF9D773C-6EED-40D6-8581-D44B45EC102CQ40296334-EB3B81DC-9041-4F2A-A06B-9333E40ACF44Q47239111-1D16B486-F06B-4B74-923E-29E88038D423Q53313887-683E14CE-B904-4837-847B-D3C82226AAB4
P2860
Interplay of troponin- and Myosin-based pathways of calcium activation in skeletal and cardiac muscle: the use of W7 as an inhibitor of thin filament activation.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Interplay of troponin- and Myo ...... r of thin filament activation.
@ast
Interplay of troponin- and Myo ...... r of thin filament activation.
@en
Interplay of troponin- and Myo ...... r of thin filament activation.
@nl
type
label
Interplay of troponin- and Myo ...... r of thin filament activation.
@ast
Interplay of troponin- and Myo ...... r of thin filament activation.
@en
Interplay of troponin- and Myo ...... r of thin filament activation.
@nl
prefLabel
Interplay of troponin- and Myo ...... r of thin filament activation.
@ast
Interplay of troponin- and Myo ...... r of thin filament activation.
@en
Interplay of troponin- and Myo ...... r of thin filament activation.
@nl
P2860
P1433
P1476
Interplay of troponin- and Myo ...... r of thin filament activation.
@en
P2093
Bishow B Adhikari
P2860
P304
P356
10.1016/S0006-3495(04)74112-0
P407
P433
P577
2004-01-01T00:00:00Z